13F-HR filed by SECTORAL ASSET MANAGEMENT INC
SECTORAL ASSET MANAGEMENT INC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-13 14:57:04 UTC, with 78 holding rows worth $157,385,316.
- Accession
- 0001104659-26-126613
- Filer
- CIK 1274413
- Filed
- 2026-11-13
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q3 2026
A holdings report, 78 entries on the cover page, a total value of $157,385,316 stated on the cover page (in dollars after the unit check, H1), rows summing to $157,385,316 with VALUE read as dollars as filed, 13F file number 028-10653. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| APNIMED INC | 03770Y107 | COM | 942,208 | $20,643,777 | dollars as filed | |
| CONTINEUM THERAPEUTICS INC CL A | 21217B100 | Stock | 689,587 | $9,254,258 | dollars as filed | |
| SHOULDER INNOVATIONS INC | 82537J108 | COMMON STOCK | 430,420 | $8,134,938 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 6,664 | $7,710,781 | dollars as filed | |
| Johnson & Johnson | 478160104 | COM | 22,758 | $6,024,953 | dollars as filed | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 7,532 | $3,937,805 | dollars as filed | |
| Gilead Sciences,Inc. | 375558103 | COM | 24,655 | $3,674,828 | dollars as filed | |
| Amgen Inc. | 031162100 | COM | 7,860 | $3,313,069 | dollars as filed | |
| AbbVie,Inc. | 00287Y109 | COM | 12,300 | $3,217,557 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 37,231 | $3,212,663 | dollars as filed | |
| SUMMIT THERAPEUTICS INC | 86627T108 | COM | 177,180 | $2,996,114 | dollars as filed | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 115,933 | $2,994,549 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 20,460 | $2,985,210 | dollars as filed | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 30,185 | $2,967,186 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 35,349 | $2,944,218 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 177,294 | $2,717,917 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 23,706 | $2,705,803 | dollars as filed | |
| ARRIVENT BIOPHARMA INC | 04272N102 | COM | 87,343 | $2,644,746 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 105,757 | $2,638,637 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 2,676 | $2,566,043 | dollars as filed | |
| IRHYTHM HOLDINGS INC COM | 450056106 | Stock | 22,570 | $2,565,306 | dollars as filed | |
| ALPHATEC HLDGS INC | 02081G201 | COM NEW | 246,150 | $2,540,268 | dollars as filed | |
| CRESCENT BIOPHARMA INC | G2545C104 | COMMON STOCK | 167,600 | $2,445,284 | dollars as filed | |
| Braveheart Bio Inc | 10567X101 | COM | 119,743 | $2,418,809 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 5,869 | $2,386,511 | dollars as filed | |
| UnitedHealth Group Inc | 91324P102 | COM | 6,208 | $2,278,833 | dollars as filed | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 2,869 | $2,175,477 | dollars as filed | |
| Stryker Corporation | 863667101 | COM | 7,829 | $2,160,859 | dollars as filed | |
| Danaher Corporation | 235851102 | COM | 9,597 | $2,128,905 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 58,100 | $2,124,717 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 225,985 | $1,984,148 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 2,908 | $1,964,203 | dollars as filed | |
| IQVIA HLDGS INC COM | 46266C105 | Stock | 7,014 | $1,885,714 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 7,385 | $1,822,175 | dollars as filed | |
| Abbott Laboratories | 002824100 | COM | 18,080 | $1,786,846 | dollars as filed | |
| TECTONIC THERAPEUTIC INC | 878972108 | COMMON STOCK | 72,592 | $1,690,668 | dollars as filed | |
| Pfizer Inc. | 717081103 | COM | 57,500 | $1,639,900 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 62,425 | $1,508,188 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 2,695 | $1,460,394 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 14,561 | $1,441,830 | dollars as filed | |
| TRANSMEDICS GROUP INC | 89377M109 | COM | 15,950 | $1,331,028 | dollars as filed | |
| PULSE BIOSCIENCES INC | 74587B101 | COMMON STOCK | 26,170 | $1,306,406 | dollars as filed | |
| CVS Health Corporation | 126650100 | COM | 13,041 | $1,117,483 | dollars as filed | |
| MODERNA INC | 60770K107 | COM | 5,300 | $1,020,621 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 15,289 | $1,007,698 | dollars as filed | |
| Medtronic Plc | G5960L103 | COM | 11,100 | $965,811 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 28,573 | $922,622 | dollars as filed | |
| Elevance Health, Inc. | 036752103 | COM | 2,006 | $779,973 | dollars as filed | |
| Bristol-Myers Squibb Company | 110122108 | COM | 12,061 | $752,606 | dollars as filed | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 12,040 | $747,925 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 14,730 | $642,965 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 10,111 | $612,171 | dollars as filed | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 6,804 | $587,321 | dollars as filed | |
| ASCENDIS PHARMA A/S | K08588103 | ORD SHS *A* | 2,570 | $585,523 | dollars as filed | |
| ILLUMINA INC | 452327109 | COM | 2,132 | $583,486 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 9,450 | $567,000 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 2,760 | $566,518 | dollars as filed | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 8,570 | $555,165 | dollars as filed | |
| HUMANA INC COM | 444859102 | Stock | 1,255 | $478,870 | dollars as filed | |
| ROYALTY PHARMA PLC | G7709Q104 | SHS CLASS A | 7,200 | $420,192 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 1,850 | $417,878 | dollars as filed | |
| GENMAB A/S | 372303206 | Ordinary Shares, nominal value DKK 1 per share | 9,900 | $353,183 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 1,980 | $353,153 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 7,200 | $321,480 | dollars as filed | |
| TEMPUS AI INC CL A | 88023B103 | Stock | 3,880 | $317,772 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 23,500 | $316,545 | dollars as filed | |
| INCYTE CORP COM | 45337C102 | Stock | 2,350 | $285,173 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 1,500 | $276,585 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 9,500 | $231,040 | dollars as filed | |
| ARDELYX INC | 039697107 | COM | 56,100 | $191,862 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 28,000 | $190,960 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 17,050 | $182,606 | dollars as filed | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 40,300 | $173,693 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 1,150 | $163,116 | dollars as filed | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 90,000 | $125,100 | dollars as filed | |
| PALISADE BIO INC | 696389402 | COMMON STOCK | 88,000 | $118,800 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 23,700 | $77,499 | dollars as filed | |
| ENGENE THERAPEUTICS INC | 29286X101 | COM | 21,700 | $43,400 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-26-126613 | this filing | 2026-11-13 |